1-4 of 4
Guus Westra
Close
Sort by
Journal Articles

Identification of a Small Subpopulation of Candidate Leukemia Initiating Cells within the Side Population (SP) of Patients with Acute Myeloid Leukemia.

Bijan Moshaver, Angele Kelder, Guus Westra, Anna van Rhenen, MD, Gert J. Ossenkoppele, MD, PhD, Sonja Zweegman, MD, PhD, Gerrit J. Schuurhuis, PhD
Journal: Blood
Blood (2007) 110 (11): 4120.
https://doi.org/10.1182/blood.V110.11.4120.4120
Published: 2007
Journal Articles

Multicolour Flow Cytometric Finetuning of the Classification of Myelodysplastic Syndromes.

Arjan A. van de Loosdrecht, MD, PhD, Theresia M. Westers, PhD, Guus Westra, Angelica Draeger, PhD, Vincent H. Van der Velden, Gert J. Ossenkoppele
Journal: Blood
Blood (2006) 108 (11): 2614.
https://doi.org/10.1182/blood.V108.11.2614.2614
Published: 2006
Journal Articles

The Novel AML Stem Cell Associated Antigen CLL-1 Discriminates between Normal and Leukemic Stem Cells.

Anna van Rhenen, Nicole Feller, Angè€le Kelder, Guus Westra, Lex Bakker, PhD, Gert Ossenkoppele, MD, PhD, Gerrit Jan Schuurhuis, PhD
Journal: Blood
Blood (2005) 106 (11): 4.
https://doi.org/10.1182/blood.V106.11.4.4
Published: 2005
Journal Articles

Immunophenotypical Sequential MRD Assessment in AML for Prediction of Relapse and Definition of Putative Future Intervention Time Points.

Nicole Feller, Peter C. Huijgens, MD, PhD, Angele Kelder, Guus Westra, Gert Ossenkoppele, MD, PhD, Gerrit J. Schuurhuis, PhD
Journal: Blood
Blood (2004) 104 (11): 3012.
https://doi.org/10.1182/blood.V104.11.3012.3012
Published: 2004